Citigroup Maintains Buy on Herbalife, Lowers Price Target to $17
Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.
Read original at benzingaStocks · News reference
Herbalife Sees Q3 Sales $1.280B-$1.331B vs $1.310B Est
Herbalife (NYSE:HLF) sees Q3 sales of $1.280 billion-$1.331 billion vs $1.310 billion analyst estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:42 PM
- Checked
- Aug 5, 2026, 8:42 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Herbalife Raises FY2026 Sales Guidance from $5.114B-$5.315B to $5.164B-$5.315B vs $5.239B Est
Herbalife (NYSE:HLF) raises FY2026 sales outlook from $5.114 billion-$5.315 billion to $5.164 billion-$5.315 billion vs $5.239 billion estimate.
Read original at benzinga8-K filing — HERBALIFE LTD. (HLF)
Filed: 2026-08-05 AccNo: 0001213900-26-085702 Size: 677 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar